Lean Toward Tocilizumab as an Add-On to Steroids for COVID-19
You'll need to apply the latest evidence for IL-6 inhibitors and Janus kinase (JAK) inhibitors to treat hospitalized COVID-19 patients.
Continue to use a steroid for COVID-19 patients on supplemental oxygen. But compare add-on options...and know when to use them.
A large meta-analysis suggests IL-6 inhibitors, mainly tocilizumab (Actemra), decrease mortality in COVID-19 patients receiving supplemental oxygen...and also taking a steroid.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote